About
Tom joined Cornerstone Search Group in 2004 and currently serves as Chief Operating…
Activity
-
Here we go again! In 5 days I am expecting to cross the Boston Marathon Finish Line now for a 3rd time. The first two times was as a milestone in…
Here we go again! In 5 days I am expecting to cross the Boston Marathon Finish Line now for a 3rd time. The first two times was as a milestone in…
Liked by Tom Fascia
-
Cornerstone was awarded Top 40 Life Sciences Search Firms Provider of 2024 byHunt Scanlon Media! Read more here
Cornerstone was awarded Top 40 Life Sciences Search Firms Provider of 2024 byHunt Scanlon Media! Read more here
Liked by Tom Fascia
-
I am excited about the opportunity to lead Pelthos Therapeutics!
I am excited about the opportunity to lead Pelthos Therapeutics!
Liked by Tom Fascia
Experience & Education
-
Cornerstone Search Group
View Tom’s full experience
See their title, tenure and more.
or
Honors & Awards
-
National Big Brother of the Year, 2014
Big Brothers Big Sisters of America
More activity by Tom
-
Incredibly humbled to be named one of the Healthcare Businesswomen’s Association 2024 Rising Stars! Thank you Otsuka Pharmaceutical Companies (U.S.)…
Incredibly humbled to be named one of the Healthcare Businesswomen’s Association 2024 Rising Stars! Thank you Otsuka Pharmaceutical Companies (U.S.)…
Liked by Tom Fascia
-
This is a big day for me personally. When I first launched Half Street Group, I thought I was just launching a practice. I wasn’t thinking about…
This is a big day for me personally. When I first launched Half Street Group, I thought I was just launching a practice. I wasn’t thinking about…
Liked by Tom Fascia
-
Today, we announced our fourth quarter and full year 2023 financial results and recent business highlights: •Initiated our pivotal spiriTED Phase 2b…
Today, we announced our fourth quarter and full year 2023 financial results and recent business highlights: •Initiated our pivotal spiriTED Phase 2b…
Liked by Tom Fascia
-
I want to express my support for the Amylyx founders, who have worked incredibly hard for over a decade to develop a life-changing treatment for ALS…
I want to express my support for the Amylyx founders, who have worked incredibly hard for over a decade to develop a life-changing treatment for ALS…
Liked by Tom Fascia
-
The Life Sciences industry isn’t like most industries—the staff that a life sciences organization selects to form its organization can make or break…
The Life Sciences industry isn’t like most industries—the staff that a life sciences organization selects to form its organization can make or break…
Liked by Tom Fascia
-
This was our very first MDA Muscle Walk over 10 years ago. Now 15, my daughter survives and thrives with Charcot-Marie-Tooth (CMT) through every…
This was our very first MDA Muscle Walk over 10 years ago. Now 15, my daughter survives and thrives with Charcot-Marie-Tooth (CMT) through every…
Liked by Tom Fascia
-
Super excited and grateful to rejoin the team to bring transformative therapies to patients!
Super excited and grateful to rejoin the team to bring transformative therapies to patients!
Liked by Tom Fascia
-
See Cornerstone in Life Science Review - Issue 40
See Cornerstone in Life Science Review - Issue 40
Liked by Tom Fascia
-
In 2022 and 2023, companies across the globe saw an increase in DEI focused efforts and diversity recruiting trends. The cultural shift traversed…
In 2022 and 2023, companies across the globe saw an increase in DEI focused efforts and diversity recruiting trends. The cultural shift traversed…
Liked by Tom Fascia
-
We are pleased to have closed today on our follow-on offering of common stock, totaling $172.5 million of gross proceeds to the company. We are…
We are pleased to have closed today on our follow-on offering of common stock, totaling $172.5 million of gross proceeds to the company. We are…
Liked by Tom Fascia
-
From our family to yours, we wish you Happy Holidays and a Happy New Year! We appreciate your support through 2023 and look forward to further…
From our family to yours, we wish you Happy Holidays and a Happy New Year! We appreciate your support through 2023 and look forward to further…
Liked by Tom Fascia
-
We are pleased to share that Tourmaline Bio (Nasdaq: TRML) will join the Nasdaq Biotechnology Index (Nasdaq: NBI) effective Monday, December 18…
We are pleased to share that Tourmaline Bio (Nasdaq: TRML) will join the Nasdaq Biotechnology Index (Nasdaq: NBI) effective Monday, December 18…
Liked by Tom Fascia
Other similar profiles
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore More